4D Medical
Update 12/12: 4DMedical jumped 10.8 per cent after securing $30.2 million in funding via an underwriting agreement with Bell Potter Securities to ensure the exercise of all its listed options.

4D Medical confirmed that the University of Miami has commenced clinical use of its CT:VQ respiratory imaging technology, becoming the second US academic medical centre after Stanford to adopt the system.
10/12 update: Hold and wait for a break below the 10-day average to close the trade.

24/11 update: Buy with a stop loss at $1.40

17/11 update:

Add to your watchlist and wait for a close above the 10-day average.

Watch Last Night’s Webinar
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Pexa
Medibank
Virgin Australia
4D Medical
4D Medical confirmed that the University of Miami has commenced clinical use of its CT:VQ respiratory imaging technology, becoming the second US academic medical centre after Stanford to adopt the system.
10/12 update: Hold and wait for a break below the 10-day average to close the trade.

24/11 update: Buy with a stop loss at $1.40

17/11 update:

Add to your watchlist and wait for a close above the 10-day average.

Watch Last Night’s Webinar
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
MongoDB
MongoDB, Inc. – Class A Common is under Algo Engine buy conditions.
The database software maker reported a revenue of $628 million, which was up 19% year over year, blowing past the $592 million expected by LSEG analysts.

Watch Last Night’s Webinar
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Send our ASX Research to your Inbox
Or start a free thirty day trial for our full service, which includes our ASX Research.



